1. Home
  2. XBIO vs EDBL Comparison

XBIO vs EDBL Comparison

Compare XBIO & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • EDBL
  • Stock Information
  • Founded
  • XBIO N/A
  • EDBL 2020
  • Country
  • XBIO United States
  • EDBL United States
  • Employees
  • XBIO N/A
  • EDBL N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • XBIO Health Care
  • EDBL Consumer Staples
  • Exchange
  • XBIO Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • XBIO 4.2M
  • EDBL 4.8M
  • IPO Year
  • XBIO N/A
  • EDBL 2022
  • Fundamental
  • Price
  • XBIO $3.52
  • EDBL $2.70
  • Analyst Decision
  • XBIO Hold
  • EDBL
  • Analyst Count
  • XBIO 1
  • EDBL 0
  • Target Price
  • XBIO N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • XBIO 179.8K
  • EDBL 99.9K
  • Earning Date
  • XBIO 08-12-2025
  • EDBL 08-13-2025
  • Dividend Yield
  • XBIO N/A
  • EDBL N/A
  • EPS Growth
  • XBIO N/A
  • EDBL N/A
  • EPS
  • XBIO N/A
  • EDBL N/A
  • Revenue
  • XBIO $2,582,728.00
  • EDBL $13,443,000.00
  • Revenue This Year
  • XBIO $14.23
  • EDBL $29.56
  • Revenue Next Year
  • XBIO $7.14
  • EDBL $20.00
  • P/E Ratio
  • XBIO N/A
  • EDBL N/A
  • Revenue Growth
  • XBIO 5.63
  • EDBL N/A
  • 52 Week Low
  • XBIO $2.20
  • EDBL $1.80
  • 52 Week High
  • XBIO $5.27
  • EDBL $39.50
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 60.67
  • EDBL 44.49
  • Support Level
  • XBIO $3.52
  • EDBL $2.55
  • Resistance Level
  • XBIO $4.09
  • EDBL $2.80
  • Average True Range (ATR)
  • XBIO 0.54
  • EDBL 0.17
  • MACD
  • XBIO 0.09
  • EDBL -0.03
  • Stochastic Oscillator
  • XBIO 45.17
  • EDBL 13.46

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: